Synthomer (SYNT) Sets New 52-Week Low at $444.00

Synthomer PLC (LON:SYNT) hit a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 444 ($5.80) and last traded at GBX 444 ($5.80), with a volume of 608052 shares. The stock had previously closed at GBX 465 ($6.08).

Several brokerages recently issued reports on SYNT. Peel Hunt reissued a “buy” rating on shares of Synthomer in a research note on Thursday. Deutsche Bank increased their price objective on Synthomer from GBX 640 ($8.36) to GBX 645 ($8.43) and gave the stock a “buy” rating in a research note on Tuesday, October 2nd. Numis Securities reissued a “hold” rating on shares of Synthomer in a research note on Monday, July 30th. JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of Synthomer in a research note on Tuesday, August 7th. Finally, UBS Group reaffirmed a “sell” rating on shares of Synthomer in a research note on Tuesday, August 7th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of GBX 556.88 ($7.28).

The company also recently declared a dividend, which will be paid on Tuesday, November 6th. Stockholders of record on Thursday, October 4th will be paid a dividend of GBX 4 ($0.05) per share. This represents a dividend yield of 0.74%. The ex-dividend date of this dividend is Thursday, October 4th.

Synthomer Company Profile (LON:SYNT)

Synthomer plc operates as a specialty chemical company in Europe, North America, Asia, and internationally. It offers adhesives for use in labels, graphics, specialty tapes, caulks and sealants, wet glues, protective films, packaging, and other applications; and high solid lattices for foamed footwear and bedding products.

Featured Story: Dollar Cost Averaging

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply